- Home
- LGCL vs PDSB Comparison
LGCL vs PDSB Comparison
Compare LGCL & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCL
- PDSB
- Stock Information
- Founded
- LGCL 2009
- PDSB 2005
- Country
- LGCL China
- PDSB United States
- Employees
- LGCL N/A
- PDSB N/A
- Industry
- LGCL
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- LGCL
- PDSB Health Care
- Exchange
- LGCL NYSE
- PDSB Nasdaq
- Market Cap
- LGCL 47.7M
- PDSB 72.2M
- IPO Year
- LGCL 2024
- PDSB N/A
- Fundamental
- Price
- LGCL $1.07
- PDSB $1.27
- Analyst Decision
- LGCL
- PDSB Strong Buy
- Analyst Count
- LGCL 0
- PDSB 2
- Target Price
- LGCL N/A
- PDSB $10.00
- AVG Volume (30 Days)
- LGCL 845.5K
- PDSB 557.2K
- Earning Date
- LGCL 01-01-0001
- PDSB 08-12-2025
- Dividend Yield
- LGCL N/A
- PDSB N/A
- EPS Growth
- LGCL N/A
- PDSB N/A
- EPS
- LGCL 0.07
- PDSB N/A
- Revenue
- LGCL $145,690,427.00
- PDSB N/A
- Revenue This Year
- LGCL N/A
- PDSB N/A
- Revenue Next Year
- LGCL N/A
- PDSB N/A
- P/E Ratio
- LGCL $15.77
- PDSB N/A
- Revenue Growth
- LGCL N/A
- PDSB N/A
- 52 Week Low
- LGCL $0.28
- PDSB $0.85
- 52 Week High
- LGCL $3.31
- PDSB $4.42
- Technical
- Relative Strength Index (RSI)
- LGCL N/A
- PDSB 37.10
- Support Level
- LGCL N/A
- PDSB $1.54
- Resistance Level
- LGCL N/A
- PDSB $1.66
- Average True Range (ATR)
- LGCL 0.00
- PDSB 0.12
- MACD
- LGCL 0.00
- PDSB -0.06
- Stochastic Oscillator
- LGCL 0.00
- PDSB 13.43
About LGCL LUCAS GC LIMITED
Lucas GC Ltd is a technology-driven online agent-centric human capital management service provider targeting professionals based on PaaS in China. Its business segments consist of recruitment services, outsourcing services, and other services, which include information technology services and training services.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.